Skip to Content
Merck
  • The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K

The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K

Vascular pharmacology (2017-10-19)
Monika Kloza, Marta Baranowska-Kuczko, Barbara Malinowska, Olga Karpińska, Ewa Harasim-Symbor, Irena Kasacka, Hanna Kozłowska
PMID29038048
ABSTRACT

The aim of this study was to examine the influence of deoxycorticosterone acetate-salt (DOCA-salt) hypertension and chronic treatment with the fatty acid amide hydrolase inhibitor, URB597, on small and intermediate conductance calcium-activated potassium channels and endothelium-dependent hyperpolarization (K